You are here

Home

Clinical Trials: Wounds and Injuries

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, January 8, 2019 - 12:00
Open-label Phase I Study for PEP or Treatment of HS-ARS PLX-R18 for the Post-Exposure Prevention (PEP) or Treatment of Hematopoietic Syndrome of Acute Radiation Syndrome (HS-ARS)
Condition:   Ionizing Radiation Exposure
Intervention:   Biological: Cell therapy
Sponsor:   Pluristem Ltd.
Not yet recruiting
Posted: Thursday, December 6, 2018 - 12:00
Regenerative Potential of Supercell Glue and Platelet Rich Fibrin Matrix
Condition:   Intrabony Periodontal Defect
Interventions:   Biological: SUPERCELL GLUE;   Biological: PRFM ALONE
Sponsor:   KLE Society's Institute of Dental Sciences
Recruiting
Posted: Tuesday, November 27, 2018 - 12:00
Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers
Condition:   Diabetic Foot Ulcer
Interventions:   Biological: ALLO-ASC-DFU;   Procedure: Hydrogel SHEET(Vehicle control)
Sponsor:   Anterogen Co., Ltd.
Recruiting
Posted: Friday, June 8, 2018 - 12:00
Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCD
Condition:   Limbal Stem Cell Deficiency
Intervention:   Biological: LSC2
Sponsors:   RHEACELL GmbH & Co. KG;   FGK Clinical Research GmbH;   Ticeba GmbH;   Granzer Regulatory Consulting & Services
Not yet recruiting
Posted: Monday, May 7, 2018 - 12:00
Use of Bone Marrow Concentrate for Treatment of Alar, Accessory, and Transverse Ligament Injuries
Condition:   Craniocervical Injuries
Interventions:   Biological: Bone Marrow Concentrate treatment;   Other: Sham Control
Sponsor:   Regenerative Sciences, LLC
Recruiting
Posted: Tuesday, March 13, 2018 - 12:00
Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora
Conditions:   Urologic Diseases;   Male Urogenital Diseases;   Penile Diseases;   Corpus Callosum Malformation;   Corpora Cavernosa; Inflammation;   Trauma Injury
Intervention:   Biological: Autologous tissue engineered corpora
Sponsors:   Wake Forest University Health Sciences;   United States Department of Defense
Not yet recruiting
Posted: Wednesday, February 28, 2018 - 12:00
Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)
Condition:   Lateral Epicondylitis
Interventions:   Biological: High concentration of Allo-ASC;   Biological: Low concentration of Allo-ASC;   Drug: Fibrin glue;   Drug: Normal saline
Sponsors:   Seoul National University Hospital;   Korea Health Industry Development Institute
Recruiting
Posted: Thursday, January 4, 2018 - 12:00
Evaluation of Outcomes With Amniotic Fluid for Musculoskeletal Conditions Musculoskeletal Conditions
Conditions:   Osteoarthritis;   Tendinitis;   Sports Injury;   Degenerative Disc Disease;   Degenerative Arthritis;   Ligament Injury;   Neuropathy;   Pelvic Pain
Intervention:   Biological: Amniotic
Sponsor:   R3 Stem Cell
Recruiting
Posted: Friday, December 29, 2017 - 12:00
the Safety/Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Healing Poor After Uterus Injury
Condition:   Uterus; Injury
Interventions:   Procedure: intrauterine injection;   Procedure: intravenous injection;   Biological: umbilical cord mesenchymal stem cell;   Drug: Normal saline (NS)
Sponsor:   Sclnow Biotechnology Co., Ltd.
Not yet recruiting
Posted: Wednesday, December 13, 2017 - 12:00
Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.
Condition:   Diabetic Foot Ulcer
Interventions:   Biological: ALLO-ASC-DFU;   Procedure: Vehicle sheet
Sponsor:   Anterogen Co., Ltd.
Not yet recruiting

Pages